Day: November 5, 2025

— Lung cancer programs progressing with interim data updates expected in Q4 2025 — — Topline data from OnPrime Phase 3 ovarian cancer registrational trial expected in the second half of 2026 — — Cash, cash equivalents, short-term investments and restricted cash of $21.0 million as of September 30, 2025 — WESTLAKE VILLAGE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the third quarter of 2025 and provided general business updates. “In the third quarter, we continued to progress Olvi-Vec’s development across multiple solid tumor indications, positioning the program for meaningful clinical milestones and key catalysts in the coming year in indications that, together, represent a multi-billion-dollar...

GAAP Net Income of $163 million, or $1.10 per diluted shareAdjusted Operating Income of $166 million, or $1.12 per diluted shareReturn on Equity of 12.4% and Adjusted Operating Return on Equity of 12.6%Primary Insurance in-force of $272 billion, a 2% year-over-year increasePMIERs Sufficiency of 162% or approximately $1.9 billionBook Value Per Share of $36.53 and Book Value Per Share excluding AOCI of $36.82Increased Full-Year Capital Return Guidance to approximately $500 million RALEIGH, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) today announced financial results for the third quarter of 2025. “Enact continues to execute with discipline and purpose,” stated Rohit Gupta, President and CEO of Enact. “We delivered another strong quarter, maintained our prudent approach to risk management...

Reaffirms 2025 adjusted earnings guidance in the range of $4.00 to $4.20 per share, excluding merger-related costs, same as prior GAAP guidance Completed planned equity and debt financing activities for 2025 Filed settlement agreement for new customer rates at Nebraska natural gas utility Completing construction of Ready Wyoming 260-mile transmission expansion project to be in service by year-end Commenced construction of Lange II 99 MW generation facility in South Dakota to be in service during second half of 2026 Announced tax-free, all-stock merger with NorthWestern Energy in August and filed joint applications for regulatory approval in Montana, Nebraska and South Dakota in OctoberRAPID CITY, S.D., Nov. 05, 2025 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced financial results for the third quarter ended...

HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today announced third-quarter 2025 results. Results can be found on the company’s website by visiting www.apacorp.com or investor.apacorp.com. APA will host a conference call on Nov. 6 at 10 a.m. Central time via the webcast link available on the company website to discuss the results. Following the conference call, a replay will be available for one year on the “Investors” page of the company’s website. About APA APA Corporation owns consolidated subsidiaries that explore for and produce oil and natural gas in the United States, Egypt and the United Kingdom and that explore for oil and natural gas offshore Suriname and elsewhere. APA posts announcements, operational updates, investor information and press releases on its website, www.apacorp.com. Contacts Investor:...

Ongoing Phase 1 trial of CTIM-76 (CLDN6 x CD3) demonstrates encouraging antitumor activity and safety Ongoing Phase 1 trial of CT-95 (MSLN x CD3) is approaching target dose levels Cash and cash equivalents of $76.9 million as of September 30, 2025 PHILADELPHIA, Nov. 05, 2025 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today provided a clinical update and reported its financial results for the third quarter ended September 30, 2025. “We believe the early clinical data for CTIM-76 provides encouraging early signs of antitumor activity for Context’s T cell engagers (“TCE”) in solid tumors where many other approaches have failed due to material safety issues or lack of efficacy,”...

Dallas, Texas, Nov. 05, 2025 (GLOBE NEWSWIRE) — CompX International Inc. (NYSE American: CIX) announced today net sales of $40.0 million for the third quarter of 2025 compared to $33.6 million in the same period of 2024. Operating income was $4.8 million in the third quarter of 2025 compared to $3.3 million in the same period of 2024. Net income was $4.2 million, or $.34 per basic and diluted common share, for the third quarter of 2025 compared to $3.5 million, or $.28 per basic and diluted common share, in the same period of 2024. For the nine months ended September 30, 2025, net sales were $120.6 million compared to $107.5 million in the previous year. Operating income was $17.0 million for the first nine months of 2025 compared to $12.1 million for the same period in 2024. Net income for the nine months ended September 30,...

Record Quarterly Revenues and an 87% Year-Over-Year  Increase in Cash Flows from Operating Activities to $64.6 Million MONTRÉAL, Nov. 05, 2025 (GLOBE NEWSWIRE) — OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) today announced its consolidated financial results for the third quarter of 2025. Amounts presented are in United States dollars, except where otherwise noted. Highlights20,326 gold equivalent ounces (“GEOs1”) earned (18,408 GEOs in Q3 20242); Revenues from royalties and streams of $71.6 million ($42.0 million in Q3 2024); Cash flows generated by operating activities of $64.6 million ($34.6 million in Q3 2024); Cash margin3 of $69.3 million or 96.7% ($40.4 million or 96.3% in Q3 2024); Net earnings of $82.8 million, $0.44 per basic share ($13.4 million, $0.07 per basic share in Q3 2024); Adjusted...

ISSAQUAH, Wash., Nov. 05, 2025 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $21.75 billion for the retail month of October, the four weeks ended November 2, 2025, an increase of 8.6 percent from $20.03 billion last year. Net sales for the first nine weeks were $48.33 billion, an increase of 8.3 percent from $44.65 billion last year. Comparable sales were as follows:  4 Weeks   9 WeeksU.S. 6.6%   5.8%Canada 6.3%   6.3%Other International 7.2%   7.9%       Total Company 6.6%   6.1%Digitally-Enabled 16.6%   21.6%       Comparable sales excluding the impacts from changes in gasoline prices and foreign exchange were as follows:  4 Weeks   9 WeeksU.S. 6.7%   5.8%Canada 8.8%   9.1%Other International 5.1%   6.4%       Total...

–  Corporate Credit Rating Upgraded to Investment-Grade  –  Reduced Net Debt by $2 Billion Since Q3’24 and Increased Liquidity to $1.1 Billion –  Executed $1.8 Billion Refinancing of Revolving Credit Facility, Lowering Cost of Capital and Extending Weighted Average Debt Maturity –  Repurchased 12.1 Million Shares Year-to-Date at a Weighted Average Price of $7.59, Totaling $92 Million –  Raises Full-Year AFFO per Share Guidance to New Range of $0.95 to $0.97 from $0.92 to $0.96 NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — Global Net Lease, Inc. (NYSE: GNL) (“GNL” or the “Company”), an internally managed real estate investment trust that focuses on acquiring and managing a globally diversified portfolio of strategically located commercial real estate properties, announced today its financial and operating results...